menu
    • menu

    Company profile for Structure Therapeutics

    NEW Drugs in Dev: 4
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Structure Therapeutics is a clinical-stage global biopharmaceutical company discovering and developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Structure Therapeutics’ pipeline includes two clinical-stage compounds that have been designed from the company’s technology platform. By leveraging Structure Therapeutics’ world-class structure-based drug discovery know-how, the...
    Structure Therapeutics is a clinical-stage global biopharmaceutical company discovering and developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Structure Therapeutics’ pipeline includes two clinical-stage compounds that have been designed from the company’s technology platform. By leveraging Structure Therapeutics’ world-class structure-based drug discovery know-how, the company aims to design differentiated small molecule therapies to overcome the limitations of biologics and peptide therapies, starting with a focus on the GPCR cell surface family of drug targets.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Structure TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    701 Gateway Blvd. Suite 410 South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://structuretx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/structuretx/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ShouTiPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Structure Therapeutics Reports Q1 2026 Results and Highlights
    Structure Therapeutics Reports Q1 2026 Results and Highlights

    07 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/07/3290577/0/en/structure-therapeutics-reports-first-quarter-2026-financial-results-and-recent-highlights.html

    GLOBENEWSWIRE
    07 May 2026
    Share Share
    Structure Therapeutics to Present Diabetes Data at ADA 2026
    Structure Therapeutics to Present Diabetes Data at ADA 2026

    27 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/27/3282005/0/en/structure-therapeutics-to-present-aleniglipron-amylin-and-combination-data-at-the-american-diabetes-association-86th-scientific-sessions.html

    GLOBENEWSWIRE
    27 Apr 2026
    Share Share
    Structure Therapeutics Appoints Lang As COO And General Counsel
    Structure Therapeutics Appoints Lang As COO And General Counsel

    14 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/14/3273897/0/en/Structure-Therapeutics-Appoints-Matthew-Lang-J-D-as-Chief-Operating-Officer-and-General-Counsel.html

    GLOBENEWSWIRE
    14 Apr 2026
    Share Share
    Structure Climbs on ‘Competitive’ Profile for Weight Loss Pill
    Structure Climbs on ‘Competitive’ Profile for Weight Loss Pill

    16 Mar 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/structure-climbs-on-highly-competitive-profile-for-weight-loss-pill

    BIOSPACE
    16 Mar 2026
    Share Share
    Roche Commits $100M To Keep Its GLP-1 Structure Sound
    Roche Commits $100M To Keep Its GLP-1 Structure Sound

    06 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/roche-shores-100m-keep-its-glp-1-structure-sound

    FIERCE BIOTECH
    06 Jan 2026
    Share Share
    Structure Therapeutics Initiates Phase 1 Study Of Oral ACCG-2671
    Structure Therapeutics Initiates Phase 1 Study Of Oral ACCG-2671

    17 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/17/3206968/0/en/Structure-Therapeutics-Announces-Initiation-of-Phase-1-Clinical-Study-of-Oral-Small-Molecule-Amylin-Receptor-Agonist-ACCG-2671-for-the-Treatment-of-Obesity.html

    GLOBENEWSWIRE
    17 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search